HairMax ensures trusted and reliable effectiveness that has proven results. We provide a worldwide solution of the highest quality, with multiple certifications and clearances by medical institutions and international governments.
8 FDA clearances
January 2007 – HairMax LaserComb granted the first ever FDA clearance as a home-use medical laser device for treatment of hair loss in males with androgenetic alopecia (pattern baldness).
November 2009 & April 2011 – HairMax received FDA clearances on new LaserComb models.
May 2011 – HairMax LaserComb granted the first ever FDA clearance as a home-use medical laser device for treatment of hair loss in females with androgenetic alopecia (pattern baldness).
August 2011 – HairMax LaserComb continues to demonstrate leadership in clinical research and FDA clearances.
September 2011 – HairMax LaserComb expanded its clearances to multiple devices to treat female hair loss.
December 2014 – The HairMax LaserBand granted FDA clearance for the treatment of androgenetic alopecia in both men and women.
June 2018 – RegrowMD Laser 272 laser cap was granted FDA Clearance for the treatment of androgenetic alopecia in both men and women. The device design utilises the unique BioLight Comfort feature which incorporates 272 laser diodes within a flexible, lightweight inner liner to optimally provide a direct flow of light energy to reach the scalp for optimal results.
International medical device registrations
Singapore – Health Sciences Authority approval
Australia – TGA approval
Brazil – ANVISA registration
Canada – Health Canada approval
Colombia – INVIMA approval
Egypt – Ministry of Health approval
European Union – Declaration of Conformity
Indonesia – Ministry of Health approval
Israel – Ministry of Health approval
Russia – Ministry of Healthcare and Social Development
Saudi Arabia – SFDA
South Korea – KFDA approval
Taiwan – FDA
Thailand – Thai FDA
United Kingdom – ASA approved efficacy claims
United States – 7 FDA 501(k) OTC clearances
International medical device registrations
Singapore – Health Sciences Authority approval
Australia – TGA approval
Brazil – ANVISA registration
Canada – Health Canada approval
Colombia – INVIMA approval
Egypt – Ministry of Health approval
European Union – Declaration of Conformity
Indonesia – Ministry of Health approval
Israel – Ministry of Health approval
Russia – Ministry of Healthcare and Social Development
Saudi Arabia – SFDA
South Korea – KFDA approval
Taiwan – FDA
Thailand – Thai FDA
United Kingdom – ASA approved efficacy claims
United States – 7 FDA 501(k) OTC clearances
Quality management systems
All manufacturing processes are state-of-the-art and ISO Quality Assured.
ISO 13485:2003 – Quality System Certification
ISO 9001:2008 – Quality System Certification
IEC60825-1:2017 – 03 ED2.0
USFA Good Manufacturing Practices (GMP) – fully compliant with 21 CFR Part 820, US FDA Quality Systems Regulations